Richard Day Research, an Evanston, Ill.-based organization, recently released the results of one of the largest national surveys on medication adherence issues for those with HIV/AIDS, according to a statement released by pharmaceutical giant Bristol-Myers Squibb.
The 403 Internet survey respondents had an average of eight years taking anti-HIV medications. Eighty-five percent reported that they understood how to take their medications properly with 69 percent stating that they completely adhered to their regimens. While 12 percent felt that taking their medication every day and on time was more difficult than expected, 60 percent said that it was easier. However, 55 percent also thought it was fine to take their doses early or late, and 17 percent reported missing two or more doses within the past week. The report stated that misconceptions can negatively impact treatment success.
Bristol-Myers Squibb underwrote the survey.